|
|
Volumn 24, Issue 6, 2006, Pages 595-596
|
|
Monoclonals expand into neural disorders
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMYLOID BETA PROTEIN;
BAPINEUZUMAB;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY AG403;
MONOCLONAL ANTIBODY RN1219;
MONOCLONAL ANTIBODY RN624;
NATALIZUMAB;
UNCLASSIFIED DRUG;
ACTIVE IMMUNIZATION;
ALZHEIMER DISEASE;
BONE PAIN;
BRAIN HEMORRHAGE;
CENTRAL NERVOUS SYSTEM DISEASE;
CLINICAL TRIAL;
DRUG MARKETING;
HUMAN;
KNEE OSTEOARTHRITIS;
KNEE PAIN;
MULTIPLE SCLEROSIS;
NONHUMAN;
NOTE;
PAIN;
PRIORITY JOURNAL;
ANTIBODIES, MONOCLONAL;
DRUG INDUSTRY;
HUMANS;
INTERINSTITUTIONAL RELATIONS;
NERVOUS SYSTEM DISEASES;
UNITED STATES;
|
|
EID: 33745105663
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0606-595 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
